Robin J. Strongin
On August 8 and 9, 2000, the Department of Health and Human Services' Office of the Assistant Secretary for Planning and Evaluation (ASPE) held a departmental meeting to further discussion of the drug pricing and related topics raised in Prescription Drug Coverage, Spending, Utilization, and Prices, a report released by ASPE in April 2000. This Forum session highlighted the findings and conclusions from that meeting, which was entitled Pharmaceutical Pricing Practices, Utilization, and Costs. It also took the lessons learned and applied them to the real-time Capitol Hill debates surrounding Medicare coverage of outpatient prescription drugs and, more broadly, prescription drug pricing.
Mark Merlis, Senior Fellow, Institute for Health Policy Solutions; Joan Sokolovsky, PhD, Program Analyst, Division of Health Financing Policy, Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services; Michael Gluck, PhD, Scholar in Residence, National Academy of Social Insurance, and Associate Research Professor, Institute for Health Care Research and Policy, Georgetown University, Anna Cook, PhD, Health Economist, Mathematica Policy Research